<DOC>
	<DOCNO>NCT01636596</DOCNO>
	<brief_summary>The objective project examine amyloid burden cognition group subject diagnose Alzheimer 's Disease ( AD ) Mild Cognitive Impairment ( MCI ) six month course insulin deliver weekly control pulsatile intravenous fashion clinical setting . The investigator central hypothesis straightforward : The investigator predict control pulsed IV infusion insulin improve cognition patient AD , improvement correlate decrease amyloid burden patient .</brief_summary>
	<brief_title>Efficacy Pulsatile IV Insulin Cognition Amyloid Burden Patients With Alzheimer 's Disease</brief_title>
	<detailed_description>Visit 1 : Consent/Assent obtain study related procedure perform . Once consent obtain subject assessed determine eligibility base study inclusion/exclusion criterion . A history physical possible neurological examination conduct . Cognitive impairment assess subject complete Folstein Mini-Mental State Exam ( MMSE ) . Qualifying subject wish participate study schedule return study orientation visit . Subjects require study partner . Subjects give copy study partner inform consent form ( ICF ) take home . A potential study partner ( ) must attend orientation visit subject . Visit 2 : Study Orientation : ICF obtain subject study partner ( ) . Subjects study partner ( ) give information require study . They give patient log keep home session discuss study staff follow session . Subjects study partner train become proficient check blood sugar one common blood glucose meter well use supply glucose cover potential hypoglycemic reaction . Subjects and/or study partner orient location control pulsatile IV insulin infusion therapy perform . They instruct park go arrive . Visit 3 : Pre-Therapy Amyloid PET scan Visits 4 - 28 : Insulin Therapy Visits : Subjects complete 25 insulin therapy session occur weekly basis , 6 month . Prior insulin treatment follow assessment complete : MMSE , CDT , QOLS , CGI . Also prior insulin therapy , well insulin therapy treatment , basal O2 C O2 measurement obtain . Pre lab collect visit 4 , mid labs visit 16 , post lab visit 28 . Visit 29 : Post-therapy Amyloid PET Scan Visit 30 : The final study visit conduct Psychopharmacology Research Clinic within one month subject complete last insulin treatment .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Mild Cognitive Impairment</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Between 50 95 year age Have clinical diagnosis Mild Cognitive Impairment Alzheimer 's Disease Have Folstein MiniMental State Exam ( MMSE ) score 15 great Be physically able take part study Females childbearing potential ( one year postmenopausal , bilateral tubal ligation , bilateral oophorectomy , hysterectomy ) Be able give inform consent study procedure ; incapable give informed consent , subject 's designated decision maker may consent behalf subject must still able confirm assent Have `` study partner '' willing accompany study visit Have major unstable medical illness , PI 's clinical judgment , prohibit interfere involvement research protocol , include diabetes Have current substance alcohol dependence , abuse within last eight week Have ApoE4 homozygous genotype</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Alzheimer 's Disease</keyword>
	<keyword>Mild Cognitive Impairment</keyword>
	<keyword>Insulin</keyword>
	<keyword>Pulsatile</keyword>
</DOC>